BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38427231)

  • 21. Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.
    Ji H; Jiang Z; Lu P; Ma L; Li C; Pan H; Fu Z; Qu X; Wang P; Deng J; Yang X; Wang J; Zhu H
    Mol Ther; 2016 Mar; 24(3):508-21. PubMed ID: 26775808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
    Moradpour M; Abdulah SNA
    Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short communication: An inducible CRISPR/dCas9 gene repression system in Lactococcus lactis.
    Xiong ZQ; Wei YY; Kong LH; Song X; Yi HX; Ai LZ
    J Dairy Sci; 2020 Jan; 103(1):161-165. PubMed ID: 31733872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex.
    He M; Zhou X; Li Z; Yin X; Han W; Zhou J; Sun X; Liu X; Yao D; Liang H
    J Am Chem Soc; 2022 Jul; 144(28):12690-12697. PubMed ID: 35792375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-dCas9 system for epigenetic editing towards therapeutic applications.
    Bhattacharjee G; Gohil N; Siruka D; Khambhati K; Maurya R; Ramakrishna S; Chu DT; Singh V
    Prog Mol Biol Transl Sci; 2023; 198():15-24. PubMed ID: 37225318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cellular Stress Response Induced by the CRISPR-dCas9 Activation System Is Not Heritable Through Cell Divisions.
    Johnston AD; Abdulrazak A; Sato H; Maqbool SB; Suzuki M; Greally JM; Simões-Pires CA
    CRISPR J; 2020 Jun; 3(3):188-197. PubMed ID: 33560917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53.
    Lawhorn IE; Ferreira JP; Wang CL
    PLoS One; 2014; 9(11):e113232. PubMed ID: 25398078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae.
    Deaner M; Mejia J; Alper HS
    ACS Synth Biol; 2017 Oct; 6(10):1931-1943. PubMed ID: 28700213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CRISPR Interference Platform for Efficient Genetic Repression in
    Wensing L; Sharma J; Uthayakumar D; Proteau Y; Chavez A; Shapiro RS
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
    Sakuma T; Sakamoto T; Yamamoto T
    Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens.
    Zhang YM; Zheng L; Xie K
    mSphere; 2023 Feb; 8(1):e0059422. PubMed ID: 36655998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific targeting of a light activated dCas9-KillerRed fusion protein generates transient, localized regions of oxidative DNA damage.
    House NCM; Parasuram R; Layer JV; Price BD
    PLoS One; 2020; 15(12):e0237759. PubMed ID: 33332350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
    Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
    Biotechnol Bioeng; 2016 Dec; 113(12):2739-2743. PubMed ID: 27240718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli.
    Cress BF; Toparlak ÖD; Guleria S; Lebovich M; Stieglitz JT; Englaender JA; Jones JA; Linhardt RJ; Koffas MA
    ACS Synth Biol; 2015 Sep; 4(9):987-1000. PubMed ID: 25822415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.
    Koopal B; Kruis AJ; Claassens NJ; Nobrega FL; van der Oost J
    ACS Synth Biol; 2019 Feb; 8(2):216-222. PubMed ID: 30668910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.